Research & Innovation
Projects
The Institut de Recerca Sant Pau develops research projects across multiple scientific areas, with the aim of generating innovative knowledge that has an impact on health. Through national and international collaborations, these projects contribute to scientific progress and the improvement of healthcare.
International Grants Unit contact
Finished
NIS 723
Impacto de la triple terapia fija con beclometasona/formoterol/glicopirronio DPI (dispositivo NEXThaler) en la enfermedad pulmonar obstructiva crónica en el mundo real: expectativas y características de los pacientes en lo que respecta a la calidad de vida relacionada con la salud: estudio TRI-NEXT
Start Date: 2025-05-01
End Date: 2025-12-31
Amount: 0,00 €
Finished
PNC00359
DTA_FUNDACIÓN CITA ALZHEIMER / ALZHEIMER FUNDAZIOA_Multicenter cohort study of discordant amyloid profiles in control subjects”
Start Date: 2025-04-08
End Date: 2026-04-08
Amount: 0,00 €
Finished
Acuerdo 175
Colaboración para financiar publicaciones científicas en el área de hematología del Grupo de Enfermedades Inflamatorias del IR Sant Pau
Start Date: 2025-04-04
End Date: 2026-04-04
Amount: 10.000,00 €
Funding body: SANOFI-AVENTIS, SA
Finished
ALZSI-2025-1501518
ALZSI-25-1501518: Genetically determined Alzheimer's Disease: Research Advances in Down Syndrome & Autosomal Dominant Alzheimer's Disease Conference
Start Date: 2025-04-01
End Date: 2025-09-30
Amount: 22.694,20 €
Funding body: ALZHEIMER'S ASSOCIATION
Call title: ALZSI-2025-1501518
Finished
Acuerdo 172
Fellowship Isabel Illa en Enfermedades Neuromusculares II edició
Start Date: 2025-03-07
End Date: 2026-03-07
Amount: 47.449,12 €
Funding body: GRIFOLS, S.A.
Finished
PNC00338
Patrocinio JORNADAS MANEJO CLINICO DE LOS ACODS EN LA UNITAT ESPECIALITZADA DE TERAPIA ANTITROMBOTICA
Start Date: 2025-03-03
End Date: 2025-03-31
Amount: 0,00 €
Funding body: DAIICHI-SANKYO ESPAÑA, SA
Finished
GTG-2023-140-OBS
Uso en la práctica clínica de enfortumab vedotina en pacientes con cáncer urotelial avanzado en España: estudio ENFANTS.
Start Date: 2025-03-03
End Date: 2025-12-31
Amount: 0,00 €
Finished
CAIN457AES16
PSO-CHALLENGE: Análisis transversal del impacto clínico de teerapias sistémicas en pacientes con psoriasis en áreas difíciles de tratar
Start Date: 2025-03-01
End Date: 2025-09-30
Amount: 0,00 €
Finished
ENTRE DONES 2025
ENTRE DONES 2025
Start Date: 2025-02-27
End Date: 2025-07-31
Amount: 583,26 €
Funding body: DONANTES SIN NIF-CIF (APORTACIONES NO 182),AMCORE BALANCE, S.L.,MYALMA 2019, S.L.
Finished
G25-2060
5 HCP para asistir al XXIV Congreso SECO, Reus, May 28-30, 2025.
Start Date: 2025-02-12
End Date: 2025-12-31
Amount: 3.737,00 €
Funding body: W.L. GORE Y ASOCIADOS, SL
Call title: GORE 2025
Finished
SYNGAP
Blood Cells as a New Resource for Clinical Research in SYNGA
Start Date: 2025-02-01
End Date: 2026-07-31
Amount: 23.517,51 €
Funding body: SYNGAP RESEARCH FUND
Call title: Blood Cells as a New Resource for Clinical Research in SYNGAP1-related Disorders
Finished
MEDTRONIC 2025
44th ISICEM International Simposium on Intensive Care and Emergency Medicine, Brussels- Belgium, 18-21 Marzo’25
Start Date: 2025-01-31
End Date: 2025-06-30
Amount: 1.523,75 €
Funding body: MEDTRONIC IBERICA, SA
Call title: Conveni MEDTRONIC IBERICA 2025
Finished
Acuerdo 171
"Patient Journey" para el paciente sometido a trasplante de médula ósea y Terapia CarT
Start Date: 2025-01-30
End Date: 2025-02-28
Amount: 5.750,00 €
Funding body: JAZZ PHARMACEUTICALS IBERIA. S.L
Finished
GINJOL 2024-13-002
A novel therapeutic target for Alzheimer's disease beyond Aβ
Start Date: 2025-01-01
End Date: 2025-12-31
Amount: 10.000,00 €
Funding body: FUNDACIO INSTITUCIO DELS CENTRES DE RECERCA DE CATALUNYA
Call title: Programa GÍNJOL 2024
Finished
G25-2046
G25-2046
Start Date: 2025-01-01
End Date: 2025-05-31
Amount: 9.600,00 €
Funding body: W.L. GORE Y ASOCIADOS, SL
Call title: GORE 2024
Finished
LT-02-19
Estudio clínico fase I, doble ciego, paralelo, comparativo, para evaluar la farmacocinética, seguridad, farmacodinamia e inmunogenicidad de IT-01 (candidato a biosimilar de omalizumab polvo liofilizado para inyección subcutánea [prueba]) respecto al medicamento xolair® polvo liofilizado para inyección subcutánea (referencia) en voluntarios sanos: Estudio CIMA
Start Date: 2025-01-01
End Date: 2025-09-30
Amount: 0,00 €
Finished
E0400089
RLD 2025 NIH-WS-ISRAEL
Start Date: 2025-01-01
End Date: 2025-12-31
Amount: 0,00 €
Finished
CV027-1151
MULTICENTER RETROSPECTIVE STUDY: CHARACTERIZING MANAGEMENT AND OUTCOMES IN SPANISH PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY - THE SMART-HCM (STUDY ON MANAGEMENT AND RESPONSE IN SPANISH PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY USING ARTIFICIAL INTELLIGENCE)
Start Date: 2025-01-01
End Date: 2025-09-30
Amount: 0,00 €
Finished
#2425_GRT-2024b
Genetically determined Alzheimer’s Disease Conference
Start Date: 2025-01-01
End Date: 2025-07-31
Amount: 10.000,00 €
Funding body: FONDATION JEROME LEJEUNE
Call title: #2425_GRT-2024b the 2nd Conference on Genetically determined Alzheimer’s Disease: Research Advances in Down Syndrome & Autosomal Dominant Alzheimer’s Disease.
Finished
Acuerdo 168
FELLOWSHIP EN INVESTIGACIÓN organizado por el Grupo de Investigación de Esclerosis Múltiple y patologías autoinmunes del sistema nervioso central del IR SANT PAU
Start Date: 2024-12-31
End Date: 2025-06-30
Amount: 15.000,00 €
Funding body: MERCK, SLU